Quick Answer
BiomX Inc. reported Total Assets of $5.78 million for the year ending 2025.
- BiomX Inc. showed a decrease of -86.6% in Total Assets from 2024 to 2025.
- This data is from BiomX Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2018 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $71.35 million | Q2 2019: $71.62 million | Q3 2019: $71.21 million | Q1 2020: $84.46 million | Q2 2020: $78.31 million | Q3 2020: $75.15 million | Q1 2021: $67.06 million | Q2 2021: $61.65 million | Q3 2021: $81.80 million | Q1 2022: $68.74 million | Q2 2022: $58.38 million | Q3 2022: $51.90 million | Q1 2023: $41.41 million | Q2 2023: $41.25 million | Q3 2023: $33.06 million | Q1 2024: $81.61 million | Q2 2024: $68.62 million | Q3 2024: $59.98 million | Q1 2025: $45.65 million | Q2 2025: $38.05 million | Q3 2025: $26.17 million.
- Over the full 10 years of available data (2018 to 2025), BiomX Inc.'s Total Assets has grown by 8,800.3%.
- Historical annual values: Fiscal year 2025: $5.78 million | Fiscal year 2024: $43.23 million | Fiscal year 2023: $25.03 million | Fiscal year 2022: $45.53 million | Fiscal year 2021: $77.99 million | Fiscal year 2020: $70.36 million | Fiscal year 2019: $92.12 million | Fiscal year 2019: $71.62 million | Fiscal year 2018: $45.33 million | Fiscal year 2018: $65.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: